Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel J Pyne

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Journal of Neurochemistry|September 2, 2006
Protean agonism of the lysophosphatidic acid receptor-1 with Ki16425 reduces nerve growth factor-induced neurite outgrowth in pheochromocytoma 12 cellsNoreen A Moughal, Catherine M Waters, William J Valentine, et al.
Cellular Signalling|June 24, 2010
FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cellsFrancesca Tonelli, Keng Gat Lim, Carolyn Loveridge, et al.
The International Journal of Biochemistry & Cell Biology|May 29, 2012
Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1bKeng Gat Lim, Francesca Tonelli, Evgeny Berdyshev, et al.
Molecular and Cellular Biology|June 3, 2010
Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cellsJaclyn S Long, Joanne Edwards, Carol Watson, et al.
The American Journal of Pathology|October 5, 2010
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patientsCarol Watson, Jaclyn S Long, Clare Orange, et al.
Cellular Signalling|January 15, 2013
The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cellsDavid G Watson, Francesca Tonelli, Manal Alossaimi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 2, 2005
Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1Catherine M Waters, Jaclyn Long, Irina Gorshkova, et al.
International Journal of Molecular Sciences|November 11, 2020
A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T LymphocytesSun-Hye Shin, Hee-Yeon Kim, Hee-Soo Yoon, et al.
Journal of Medicinal Chemistry|March 20, 2019
Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2David R Adams, Salha Tawati, Giacomo Berretta, et al.
Gene|December 4, 2012
The p.Arg86Gln change in GARP2 (glutamic acid-rich protein-2) is a common West African-related polymorphismAbdullah A Y Gibriel, Rothwelle J Tate, Yongbin Yu, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Journal of Neurochemistry|September 2, 2006
Protean agonism of the lysophosphatidic acid receptor-1 with Ki16425 reduces nerve growth factor-induced neurite outgrowth in pheochromocytoma 12 cellsNoreen A Moughal, Catherine M Waters, William J Valentine, et al.
Cellular Signalling|June 24, 2010
FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cellsFrancesca Tonelli, Keng Gat Lim, Carolyn Loveridge, et al.
The International Journal of Biochemistry & Cell Biology|May 29, 2012
Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1bKeng Gat Lim, Francesca Tonelli, Evgeny Berdyshev, et al.
Molecular and Cellular Biology|June 3, 2010
Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cellsJaclyn S Long, Joanne Edwards, Carol Watson, et al.
The American Journal of Pathology|October 5, 2010
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patientsCarol Watson, Jaclyn S Long, Clare Orange, et al.
Cellular Signalling|January 15, 2013
The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cellsDavid G Watson, Francesca Tonelli, Manal Alossaimi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 2, 2005
Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1Catherine M Waters, Jaclyn Long, Irina Gorshkova, et al.
International Journal of Molecular Sciences|November 11, 2020
A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T LymphocytesSun-Hye Shin, Hee-Yeon Kim, Hee-Soo Yoon, et al.
Journal of Medicinal Chemistry|March 20, 2019
Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2David R Adams, Salha Tawati, Giacomo Berretta, et al.
Gene|December 4, 2012
The p.Arg86Gln change in GARP2 (glutamic acid-rich protein-2) is a common West African-related polymorphismAbdullah A Y Gibriel, Rothwelle J Tate, Yongbin Yu, et al.
Pageof 11